Company registration number 14097421 (England and Wales)
CHELTENHAM AESTHETICS LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2026
PAGES FOR FILING WITH REGISTRAR
CHELTENHAM AESTHETICS LTD
CONTENTS
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 5
CHELTENHAM AESTHETICS LTD
STATEMENT OF FINANCIAL POSITION
AS AT
31 MAY 2026
31 May 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
3
8,948
6,196
Current assets
Stocks
2,000
2,000
Debtors
610
1,241
Cash at bank and in hand
4,325
16,890
6,935
20,131
Creditors: amounts falling due within one year
(10,106)
(19,525)
Net current (liabilities)/assets
(3,171)
606
Total assets less current liabilities
5,777
6,802
Provisions for liabilities
(778)
(1,549)
Net assets
4,999
5,253
Capital and reserves
Called up share capital
4
1
1
Profit and loss reserves
4,998
5,252
Total equity
4,999
5,253
CHELTENHAM AESTHETICS LTD
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
31 MAY 2026
31 May 2026
- 2 -

For the financial year ended 31 May 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with section 444 of the Companies Act 2006, all of the members of the company have consented to the preparation of abridged financial statements pursuant to paragraph 1A of Schedule 1 to the Small Companies and Groups (Accounts and Directors’ Report) Regulations (SI 2008/409)(b).

The director of the company has elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 17 August 2026
Miss S C Newell
Director
Company registration number 14097421 (England and Wales)
CHELTENHAM AESTHETICS LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2026
- 3 -
1
Accounting policies
Company information

Cheltenham Aesthetics Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 20b The Courtyard, Montpellier Street, Cheltenham, Gloucestershire, England, GL50 1SR.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
33% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

CHELTENHAM AESTHETICS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2026
1
Accounting policies
(Continued)
- 4 -
1.5
Taxation

Taxation for the period comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

1.6
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
2
2
3
Tangible fixed assets
Plant and equipment
£
Cost
At 1 June 2025
31,005
Additions
10,560
At 31 May 2026
41,565
Depreciation and impairment
At 1 June 2025
24,809
Depreciation charged in the year
7,808
At 31 May 2026
32,617
CHELTENHAM AESTHETICS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2026
3
Tangible fixed assets
Plant and equipment
£
(Continued)
- 5 -
Carrying amount
At 31 May 2026
8,948
At 31 May 2025
6,196
4
Called up share capital
2026
2025
Ordinary share capital
£
£
Issued and fully paid
of £1 each
1
1
5
Related party transactions

Miss S C Newell

Director and shareholder

 

In a previous period, the director loaned the company £5,321. During the year, the director loaned a further £5,333 to the company. The amount is unsecured, interest-free and repayable on demand. The amount owed to the director at the year end is £10,654 (2025: £5,321)

 

Tivoli Hot Wax Limited

A company in which Miss Newell is a shareholder and director.

 

In a previous period, the company owed Tivoli Hot Wax Limited £9,552. During the year, £9,552 was repaid and a further £609 was loaned to the related party. The outstanding amount owed to the company at the year end is £609 (2025: £9,552 Creditor). The amount is unsecured, interest-free and repayable on demand.

2026-05-312025-06-01falsefalsefalse17 August 2026CCH SoftwareCCH Accounts Production 2026.200No description of principal activityMiss S C Newell140974212025-06-012026-05-31140974212026-05-31140974212025-05-3114097421core:WithinOneYear2026-05-3114097421core:WithinOneYear2025-05-3114097421core:CurrentFinancialInstrumentscore:WithinOneYear2026-05-3114097421core:CurrentFinancialInstrumentscore:WithinOneYear2025-05-3114097421core:ShareCapital2026-05-3114097421core:ShareCapital2025-05-3114097421core:RetainedEarningsAccumulatedLosses2026-05-3114097421core:RetainedEarningsAccumulatedLosses2025-05-3114097421core:ShareCapitalOrdinaryShareClass12026-05-3114097421core:ShareCapitalOrdinaryShareClass12025-05-3114097421bus:Director12025-06-012026-05-3114097421core:PlantMachinery2025-06-012026-05-31140974212024-06-012025-05-3114097421core:PlantMachinery2025-05-3114097421core:PlantMachinery2026-05-3114097421core:PlantMachinery2025-05-3114097421bus:OrdinaryShareClass12025-06-012026-05-3114097421bus:PrivateLimitedCompanyLtd2025-06-012026-05-3114097421bus:SmallCompaniesRegimeForAccounts2025-06-012026-05-3114097421bus:FRS1022025-06-012026-05-3114097421bus:AuditExempt-NoAccountantsReport2025-06-012026-05-3114097421bus:FullAccounts2025-06-012026-05-31xbrli:purexbrli:sharesiso4217:GBP